Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation.
Sébastien DefermPhilippe B BertrandDavid VerhaertJeroen DauwJan M Van KeerAlexander Van De BruaeneMarie-Christine HerregodsBart MeurisPeter VerbruggheSteffen RexPieter M VandervoortFilip RegaPublished in: Heart (British Cardiac Society) (2021)
Prognosis following MVA to treat ASMR is better, compared with VSMR as reflected by lower all-cause mortality and MR recurrence. Early distinction of secondary MR towards underlying ventricular versus atrial disease has important therapeutic implications.